Navigation Links
High resolution 'snapshots' detail dynamics of a cocaine antibody

Cocaine-binding antibodies have shown some promise in their ability to neutralize cocaine toxicity, but their binding ability is severely impaired by high concentrations of the drug. A catalytic monoclonal antibody such as 7A1, on the other hand, has the ability to regenerate after each new dose of the drug, making it far more effective than others in metabolizing cocaine.

The study, which will be published in the February issue (Volume 14 Issue 2) of the journal Structure, was led by Ian A. Wilson, D.Phil., of Scripps Research Department of Molecular Biology and The Skaggs Institute for Chemical Biology, and Kim D. Janda, Ph.D., of Scripps Research Departments of Chemistry and Immunology and The Skaggs Institute for Chemical Biology.

Despite intensive research, cocaine abuse continues to be a major public health problem, so far eluding efforts at developing an effective therapeutic agent to counter the craving, addiction, and overdose of the drug. To date, no treatment has been approved by the Food and Drug Administration (FDA).

Commenting on the new findings, Xueyong Zhu, Ph.D., the primary author of the study and a staff scientist in the Wilson laboratory said, "Development of effective therapies for cocaine abuse has been a long-standing goal, and a number of medications under study do show some promise. Immunopharmacotherapy has been proposed as a way to neutralize the drug outside the central nervous system- basically soaking up the drug before it has a chance to cross the blood brain barrier-as a potentially effective new approach to treat cocaine abuse."

Using a monoclonal antibody endowed not only with high binding ability, but also with sufficient catalytic activity to metabolize cocaine, would have potentially enhanced therapeutic effects, Zhu said. This antibody could intercept cocaine in the blood stream before it reaches the central nervous system-stopping the drug cold. Because cocaine has a half life of approximately 30
'"/>

Source:Scripps Research Institute


Page: 1 2 3

Related biology news :

1. New law for resolution allows unprecedented sharpness in fluorescence microscopy
2. High-resolution light microscope reveals the fundamental mechanisms of nerve communication
3. Recombination protein dynamics observed with single monomer resolution
4. With record resolution and sensitivity, tool images how life organizes in a cell membrane
5. Scientists take snapshots of enzyme action
6. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
7. Researcher uncovers details of how cancer spreads
8. Defective immune system response to smallpox vaccine detailed in new study
9. Research details how a virus hijacks cell signals to cause infection
10. Study reveals details of mussels tenacious bonds
11. Study details hepatitis C ability to block immune system response

Post Your Comments:
(Date:11/4/2009)..., N.Y., Oct. 21 What,s the cost of...g accidental death resulting from prescription med...good intentions, however, may be unaware that the ...eir teens from the ticking timebomb of prescriptio...in premium-quality medical supplies, has formed an...
(Date:11/4/2009)...APEL HILL Scientists at the University of North C...University of California, San Francisco have devel...ict new target diseases for existing drugs. , Th...t compares how similar the structures of all known...ners -- known as ligands -- of disease targets wit...
(Date:11/3/2009)... RATON, FL (November 4, 2009) For more than 25 ye...en conch ( Strombus gigas ) have been unsuccessful...ry seeding techniques to produce beaded (nucleated...nch have been developed by scientists from Florida... Institute (HBOI). With less than two years of res...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3HPV vaccine could prevent breast cancer 3A Australian research 56154 1HPV vaccine could prevent breast cancer 3A Australian research 56154 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 1Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 3NIBIB scientists increase imaging efficiency in cell structure studies 56150 1NIBIB scientists increase imaging efficiency in cell structure studies 56150 2
...single vaccine could be used to protect chickens, ...rding to an article published in the November issu...e protects birds and mammals against different flu... are still in their eggs, allowing the mass vaccin...has posed a major challenge to scientists designin...
...In a disease like ALS - one that,s always fatal an...ology - finding a proof of principle in animal mod...searchers report that transplanting a new line of ...e clearly shifts key signs of neurodegenerative di...he animals, neuron loss and extending life. , The...
...searchers at Emory University and Georgia Institut...that can slowly release anti-inflammatory drugs an...jected into rats, hearts after a simulated heart a...nflammation and scarring, the researchers found.,I...tissue formed after the heart attack in half and b...
Other Biology News:Bird flu vaccine protects people and pets 2Swamping bad cells with good in ALS animal models helps sustain breathing 2Swamping bad cells with good in ALS animal models helps sustain breathing 3Drug-embedded microparticles bolster heart function in animal studies 2
(Date:11/7/2009)...v. 7, Research projects in the are...s this evening, as Tim Kunisky of Livingston, NJ a...of Audubon, PA received the highest honors at the ... in Math, Science & Technology, the nation,s p...ttp://www.newscom.com/cgi-bin/prnh/20070904/SIEMEN...
(Date:11/6/2009).... 6 Helix BioPharma Corp...ounced that John Docherty, president and chief ope...rd,s 6th annual Investor Summit on November 10, 20...y. Mr. Docherty will provide an overview of the C...S47 and Topical Interferon Alpha-2b. The slide sh...
(Date:11/6/2009)...ov. 6 ,, 3Q09 Corp...utenza(TM) E.U. Marketing Authorization to Astella...n commercial readiness activities Expanded manage...rketing; and Director, Commercial Operations Appo... Audit Committee chairman , Upcoming 2009 M...
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...ideas passed muster in the first round of the Gove...ednesday. , ,They were chosen from 188 submissions...their businesses and represent various municipalit...kee areas. , ,That,s down from 200 entries last ye...gher, chairman of the Wisconsin Technology Council...
...in break Thursday at the Milwaukee County Grounds ...iday to 37 companies in the Milwaukee County Resea...rks director of development said businesses in the...nconvenience. , ,Guy T. Mascari, whose office is l...ation Center, said the center is the only building...
...lor of research in the history of the University o...ng to change its image from a university of access...elp Milwaukee build a knowledge-based economy. , ,...Wisconsins 2006 Technology Achievement Awards, app...ive. Citing Atlanta as a potential model, he said ...
Other Biology Technology:Tech awards keynoter asks for support of UWM transformation 2Tech awards keynoter asks for support of UWM transformation 3
Mouse Anti-Human p53, wild & mutant, aa 19-26 Monoclonal Antibody, Unconjugated, Clone DO-7 from CHEMICON
Tube-O-DIALYZER Floats, Floats, Small from CHEMICON
Anti-Feline Rhinotracheitis Virus Monoclonal Antibody, Unconjugated from ViroStat Inc.
Anti-Ezrin / Radixin / Moesin Antibody, Unconjugated from Cell Signaling Technology
Biology Products: